Nomura Securities Maintains a 'Buy' on Varian Medical (VAR); Raising Estimates on Solid Report

July 26, 2012 11:17 AM EDT Send to a Friend
Get Alerts VAR Hot Sheet
Price: $67.30 -0.87%

Rating Summary:
    13 Buy, 4 Hold, 2 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 11 | Down: 16 | New: 13
Trade VAR Now!
Nomura Securities maintains a 'Buy' on Varian Medical (NYSE: VAR) price target of $70.00.

Analyst, Martin Brunninger, said, "3Q2012 results summary: Solid set of numbers, top line +9% to USD 705m (+11% constant currency), marginally below consensus (~0.8%). EBIT ~3% above consensus following a promising margin improvement of 20bps to 21.8% (well above the 20.0% reported in Q212). Diluted EPS +16% to USD 0.96/share. 2012 outlook revised down slightly against backdrop of challenging currency environment, net sales +8% for year (+10% in Q2) and diluted EPS from continuing operations +8 to 9% (+9 to 12% in Q2)."

FY12 EPS raised from $1.63 to $1.70; FY13 EPS from $2.00 to $2.10.

For an analyst ratings summary and ratings history on Varian Medical click here. For more ratings news on Varian Medical click here.

Shares of Varian Medical closed at $57.31 yesterday, with a 52 week range of $48.72-$71.95.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View

Related Entities

Nomura

Add Your Comment